High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.
about
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisSerum IL-33 level is a predictor of progression-free survival after chemotherapy.An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control StudyRole of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma.Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Significance of interleukin-33 and its related cytokines in patients with breast cancers.The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.Interleukin-33 in human gliomas: Expression and prognostic significance.IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.IL-33-ST2 Axis in Liver Disease: Progression and Challenge.dTCApFs, a derivative of a novel human hormone peptide, induces apoptosis in cancer cells through a mechanism involving loss of Golgi function.The family of the interleukin-1 receptors.Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients.Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang CytokineThe Role of IL-33/ST2 Pathway in TumorigenesisIL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
P2860
Q28069174-979B3D5C-64A2-41C7-98F1-3D97D12D2304Q33798754-3B1C3045-F2D5-4D8F-A5A0-0C29B100C21FQ36473012-DD68DEC2-6ABE-4C76-A7E5-5D0A8EF2C4D7Q37000128-C319313F-01F5-43DF-A378-5CD7089C2D20Q37001426-33DAFA42-71F1-458C-AAD2-5CF28B51DAC2Q37328464-1DA10551-F8DB-4830-8C1E-A97559FB169CQ37571181-1B8247BB-B3D5-4D09-A3BF-253A62A0E3AAQ37700227-7DF3F489-48EA-4703-B941-DABC5F0B9B60Q38224933-464857E7-8CC1-464D-B241-DE392D78D867Q38753216-0D6E22BA-9C93-4B23-95A5-64129EC4B9F9Q38775054-49190C77-C46B-48B3-9C92-35B997522503Q38912671-87D27498-8C92-40D4-8E63-09E35811B962Q39653025-5C4E9266-C22E-49F2-A3A4-1C8F2A3C498DQ40146282-AB9F369D-5BDE-4F1C-AA3D-BA64BE81A3EDQ40312760-212CB422-BB49-4054-8418-9AA328D209ECQ40470696-BBB83A2D-C59B-4061-9731-D47A48C7D8C6Q41489558-FB127498-8DF4-4AEC-828F-4CC4ED1DA64DQ42201038-BE7A3F6D-2485-4587-B528-0CCF2E64DEC5Q45863196-F2991F52-927D-4B8B-962D-7BC1D8B23A4DQ46866026-B65BFE65-804A-4131-9A94-96E1F92DC682Q47127784-B22FBD46-D391-4DA3-AFC4-0B86E1FD14D1Q47145897-973DE53F-72E3-4747-A9AD-B4E09A08F11FQ47285858-82C84DB5-B1D7-4B4C-822B-459A48A9AC26Q48120429-541A7FB9-5D5E-4485-8BC0-467D05B436F5Q48168794-62D80D81-21A8-412A-AE2D-D2D0D7839FF4Q51070624-4AA811E7-0741-4652-8B70-7A41A71CA7CDQ52141871-42B57C74-499D-4322-A190-2D2E75D202FFQ58707724-AB7E852D-640E-45F4-9E1B-67E6502FED6BQ58756972-525F82AE-1138-411A-8E2C-64B1E4260BECQ58770481-CE474185-3D56-4684-867B-4280E05C4CCF
P2860
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
High Serum Levels of the Inter ...... r in Hepatocellular Carcinoma.
@en
type
label
High Serum Levels of the Inter ...... r in Hepatocellular Carcinoma.
@en
prefLabel
High Serum Levels of the Inter ...... r in Hepatocellular Carcinoma.
@en
P2093
P2860
P356
P1476
High Serum Levels of the Inter ...... r in Hepatocellular Carcinoma.
@en
P2093
Annika Ranglack
Bernd Kronenberger
Dominik Bergis
Heinfried H Radeke
Oliver Waidmann
Valentin Kassis
Verena Koeberle
P2860
P304
P356
10.1593/TLO.12418
P577
2013-06-01T00:00:00Z